RIGEL PHARMACEUTICALS INC — Director's Dealing 2017

May 12, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RIGEL PHARMACEUTICALS INC (RIGL)
CIK: 0001034842
Period of Report: 2017-05-12

Reporting Person: Goodwin Bradford S (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-05-12	Stock Option (Right to Buy)	$2.61	A	40000	Acquired	2027-05-12	Common Stock (40000)	Direct

Footnotes

F1: The shares vest monthly over twelve (12) months from the date of grant.